Latest news
Dostarlimab Monotherapy Elicits Responses in First-Line PD-L1-Positive HNSCC - OncLiveOncLive · Fri, 07 Aug 2026 15:25:50 GMTFrontline Zanubrutinib Plus Obinutuzumab Elicits Complete Responses in Older Patients With MCL - OncLiveOncLive · Mon, 03 Aug 2026 13:08:13 GMTCretostimogene Grenadenorepvec Elicits Durable Complete Responses and Bladder Preservation in BCG-Unresponsive NMIBC - OncLiveOncLive · Tue, 28 Jul 2026 07:00:00 GMT